Diabetes Packaging Pharmaceutical Companies 
STAT
OCTOBER 10, 2024
billion deal in which Novo Nordisk’s parent foundation would acquire Catalent, a leading contract drug manufacturer, over concerns the acquisition would give the pharmaceutical company an unfair advantage in the burgeoning market for drugs used to treat obesity and diabetes.
STAT
OCTOBER 31, 2024
Of course, this calls for a cup of stimulation, and we are opening a new package of pecan pie for the occasion. … All doses of Novo Nordisk’s blockbuster diabetes and obesity treatments are listed as available on the U.S. What is upon us right now, however, is our ever-growing to-do list. Sound familiar?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
OCTOBER 17, 2022
Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.
Express Pharma
MARCH 16, 2025
In India, pharmaceutical companies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques. Indian pharmaceutical companies have specialised in reverse-engineering complex medicines and producing biosimilars as alternatives to costly biologics.
Pharmafile
JANUARY 25, 2023
US-based pharmaceutical company, Eli Lilly and Company, has announced plans to invest $450m in its manufacturing facilities at Research Triangle Park in North Carolina, US. The facility is expected to become operational in 2027 and will create over 100 new jobs for manufacturing personnel. read more
Fuld & Company Blog
MARCH 27, 2023
The background of semaglutide Nearly 20 years ago the first glucagon-like peptide 1 (GLP-1), a class of Type 2 diabetes drug that improves blood sugar, was launched, creating what is today a market worth nearly $30B. This market was estimated to be worth over $80 billion, in addition to the $30 billion diabetes market.
The Thyroid Pharmacist
OCTOBER 27, 2023
Follow package instructions. In one study, one gram of berberine per day lowered fasting blood sugar by 20 percent in people with diabetes, which is comparable to a commonly prescribed diabetes medication. [8] Follow package directions for each supplement. The herb itself can be poisonous if ingested.
Expert insights. Personalized for you.
294 
Let's personalize your content